These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

870 related items for PubMed ID: 25500889

  • 1. TALEN-mediated targeting of HPV oncogenes ameliorates HPV-related cervical malignancy.
    Hu Z, Ding W, Zhu D, Yu L, Jiang X, Wang X, Zhang C, Wang L, Ji T, Liu D, He D, Xia X, Zhu T, Wei J, Wu P, Wang C, Xi L, Gao Q, Chen G, Liu R, Li K, Li S, Wang S, Zhou J, Ma D, Wang H.
    J Clin Invest; 2015 Jan; 125(1):425-36. PubMed ID: 25500889
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Zinc finger nucleases targeting the human papillomavirus E7 oncogene induce E7 disruption and a transformed phenotype in HPV16/18-positive cervical cancer cells.
    Ding W, Hu Z, Zhu D, Jiang X, Yu L, Wang X, Zhang C, Wang L, Ji T, Li K, He D, Xia X, Liu D, Zhou J, Ma D, Wang H.
    Clin Cancer Res; 2014 Dec 15; 20(24):6495-503. PubMed ID: 25336692
    [Abstract] [Full Text] [Related]

  • 4. Eradication of cervical cancer in vivo by an AAV vector that encodes shRNA targeting human papillomavirus type 16 E6/E7.
    Sato N, Saga Y, Uchibori R, Tsukahara T, Urabe M, Kume A, Fujiwara H, Suzuki M, Ozawa K, Mizukami H.
    Int J Oncol; 2018 Mar 15; 52(3):687-696. PubMed ID: 29344635
    [Abstract] [Full Text] [Related]

  • 5. Tanshinone IIA inhibits viral oncogene expression leading to apoptosis and inhibition of cervical cancer.
    Munagala R, Aqil F, Jeyabalan J, Gupta RC.
    Cancer Lett; 2015 Jan 28; 356(2 Pt B):536-46. PubMed ID: 25304375
    [Abstract] [Full Text] [Related]

  • 6. Inhibition of cervical cancer cell growth in vitro and in vivo by lentiviral-vector mediated shRNA targeting the common promoter of HPV16 E6 and E7 oncogenes.
    Zhou J, Li B, Peng C, Wang F, Fu Z, Zhou C, Hong D, Ye F, Lü W, Xie X.
    Antiviral Res; 2013 May 28; 98(2):305-13. PubMed ID: 23523766
    [Abstract] [Full Text] [Related]

  • 7. The synergistic therapeutic effect of cisplatin with Human papillomavirus E6/E7 short interfering RNA on cervical cancer cell lines in vitro and in vivo.
    Jung HS, Erkin OC, Kwon MJ, Kim SH, Jung JI, Oh YK, Her SW, Ju W, Choi YL, Song SY, Kim JK, Kim YD, Shim GY, Shin YK.
    Int J Cancer; 2012 Apr 15; 130(8):1925-36. PubMed ID: 21630254
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Systemic delivery of siRNA by actively targeted polyion complex micelles for silencing the E6 and E7 human papillomavirus oncogenes.
    Nishida H, Matsumoto Y, Kawana K, Christie RJ, Naito M, Kim BS, Toh K, Min HS, Yi Y, Matsumoto Y, Kim HJ, Miyata K, Taguchi A, Tomio K, Yamashita A, Inoue T, Nakamura H, Fujimoto A, Sato M, Yoshida M, Adachi K, Arimoto T, Wada-Hiraike O, Oda K, Nagamatsu T, Nishiyama N, Kataoka K, Osuga Y, Fujii T.
    J Control Release; 2016 Jun 10; 231():29-37. PubMed ID: 26979870
    [Abstract] [Full Text] [Related]

  • 10. Transcriptional gene silencing of HPV16 E6/E7 induces growth inhibition via apoptosis in vitro and in vivo.
    Zhou J, Peng C, Li B, Wang F, Zhou C, Hong D, Ye F, Cheng X, Lü W, Xie X.
    Gynecol Oncol; 2012 Feb 10; 124(2):296-302. PubMed ID: 22056554
    [Abstract] [Full Text] [Related]

  • 11. Antisense targeting human papillomavirus type 16 E6 and E7 genes contributes to apoptosis and senescence in SiHa cervical carcinoma cells.
    Sima N, Wang S, Wang W, Kong D, Xu Q, Tian X, Luo A, Zhou J, Xu G, Meng L, Lu Y, Ma D.
    Gynecol Oncol; 2007 Aug 10; 106(2):299-304. PubMed ID: 17586029
    [Abstract] [Full Text] [Related]

  • 12. A novel MLL5 isoform that is essential to activate E6 and E7 transcription in HPV16/18-associated cervical cancers.
    Yew CW, Lee P, Chan WK, Lim VK, Tay SK, Tan TM, Deng LW.
    Cancer Res; 2011 Nov 01; 71(21):6696-707. PubMed ID: 21908553
    [Abstract] [Full Text] [Related]

  • 13. Human Papillomavirus E6/E7-Specific siRNA Potentiates the Effect of Radiotherapy for Cervical Cancer in Vitro and in Vivo.
    Jung HS, Rajasekaran N, Song SY, Kim YD, Hong S, Choi HJ, Kim YS, Choi JS, Choi YL, Shin YK.
    Int J Mol Sci; 2015 May 29; 16(6):12243-60. PubMed ID: 26035754
    [Abstract] [Full Text] [Related]

  • 14. HPV16 oncogenes E6 or/and E7 may influence the methylation status of RASSFIA gene promoter region in cervical cancer cell line HT-3.
    Yin F, Wang N, Wang S, Yu F, Sun X, Yu X, Luo B, Zhao C, Wang Y.
    Oncol Rep; 2017 Apr 29; 37(4):2324-2334. PubMed ID: 28260046
    [Abstract] [Full Text] [Related]

  • 15. Human Papillomavirus 16 Oncoprotein Expression Is Controlled by the Cellular Splicing Factor SRSF2 (SC35).
    McFarlane M, MacDonald AI, Stevenson A, Graham SV.
    J Virol; 2015 May 29; 89(10):5276-87. PubMed ID: 25717103
    [Abstract] [Full Text] [Related]

  • 16. Wogonin induces apoptosis by suppressing E6 and E7 expressions and activating intrinsic signaling pathways in HPV-16 cervical cancer cells.
    Kim MS, Bak Y, Park YS, Lee DH, Kim JH, Kang JW, Song HH, Oh SR, Yoon DY.
    Cell Biol Toxicol; 2013 Aug 29; 29(4):259-72. PubMed ID: 23955116
    [Abstract] [Full Text] [Related]

  • 17. HPV E6/E7 promotes aerobic glycolysis in cervical cancer by regulating IGF2BP2 to stabilize m6A-MYC expression.
    Hu C, Liu T, Han C, Xuan Y, Jiang D, Sun Y, Zhang X, Zhang W, Xu Y, Liu Y, Pan J, Wang J, Fan J, Che Y, Huang Y, Zhang J, Ding J, Yang S, Yang K.
    Int J Biol Sci; 2022 Aug 29; 18(2):507-521. PubMed ID: 35002506
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 44.